Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · The Lancet · 556 citations
https://doi.org/10.1016/s0140-6736(21)00149-5
M
Maria R. Amezaga
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
29
Papers
2.9K
Citations
16
h-index
16
i10-index
Maria R. Amezaga is an academic researcher. The author has contributed to research in topics: Effects and risks of endocrine disrupting chemicals & Toxic Organic Pollutants Impact & COVID-19 Clinical Research Studies. The author has an h-index of 16, co-authored 25 publications.
Papers by this author
worksConvalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · The Lancet · 516 citations
https://doi.org/10.1016/s0140-6736(21)00897-7
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · The Lancet · 320 citations
https://doi.org/10.1016/s0140-6736(22)01109-6
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · The Lancet · 289 citations
https://doi.org/10.1016/s0140-6736(21)01825-0
The fetal ovary exhibits temporal sensitivity to a ‘real-life’ mixture of environmental chemicals
2016 · Scientific Reports · 49 citations
https://doi.org/10.1038/srep22279
Exposure to chemical cocktails before or after conception – The effect of timing on ovarian development
2013 · Molecular and Cellular Endocrinology · 42 citations
https://doi.org/10.1016/j.mce.2013.06.016
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat